Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 296

1.

The way forward in Italy for iodine.

Olivieri A, DI Cosmo C, DE Angelis S, DA Cas R, Stacchini P, Pastorelli A, Vitti P; Regional Observatories for Goiter Prevention..

Minerva Med. 2017 Jan 12. doi: 10.23736/S0026-4806.17.04877-7. [Epub ahead of print]

PMID:
28079352
2.

Iodine nutritional status and thyroid effects of exposure to ethylenebisdithiocarbamates.

Medda E, Santini F, De Angelis S, Franzellin F, Fiumalbi C, Perico A, Gilardi E, Mechi MT, Marsili A, Citroni A, Leandri A, Mantovani A, Vitti P, Olivieri A.

Environ Res. 2017 Jan 7;154:152-159. doi: 10.1016/j.envres.2016.12.019. [Epub ahead of print]

PMID:
28073049
3.

Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study.

Leo M, Maggi F, Dottore GR, Casini G, Mazzetti P, Pistello M, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marinò M.

J Endocrinol Invest. 2016 Dec 16. [Epub ahead of print]

PMID:
27987077
4.

Postoperative thyroglobulin and neck ultrasound in the risk re-stratification and decision to perform 131I ablation.

Matrone A, Gambale C, Piaggi P, Viola D, Giani C, Agate L, Bottici V, Bianchi F, Materazzi G, Vitti P, Molinaro E, Elisei R.

J Clin Endocrinol Metab. 2016 Dec 8:jc20162860. [Epub ahead of print]

PMID:
27929713
5.

Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy.

Rotondo Dottore G, Leo M, Casini G, Latrofa F, Cestari L, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marinò M.

Thyroid. 2016 Dec 16. [Epub ahead of print]

PMID:
27824294
6.

Low Elasticity of Thyroid Nodules on Ultrasound Elastography Is Correlated with Malignancy, Degree of Fibrosis, and High Expression of Galectin-3 and Fibronectin-1.

Rago T, Scutari M, Loiacono V, Santini F, Tonacchera M, Torregrossa L, Giannini R, Borrelli N, Proietti A, Basolo F, Miccoli P, Piaggi P, Latrofa F, Vitti P.

Thyroid. 2017 Jan;27(1):103-110. doi: 10.1089/thy.2016.0341.

PMID:
27809694
7.

Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.

Sabini E, Sisti E, Coco B, Leo M, Ionni I, Menconi F, Profilo MA, Mazzi B, Rocchi R, Latrofa F, Vitti P, Brunetto M, Marcocci C, Marinò M.

J Endocrinol Invest. 2016 Nov;39(11):1323-1327.

PMID:
27465669
8.

Papillary thyroid cancer in a patient with congenital goitrous hypothyroidism due to a novel deletion in NIS gene.

Agretti P, Bagattini B, De Marco G, Di Cosmo C, Dionigi G, Vitti P, Tonacchera M.

Endocrine. 2016 Oct;54(1):256-258. No abstract available.

PMID:
26563437
9.

Role of YAP-1 in Thyroid Tumor Progression and Outcome.

Ugolini C, Borrelli N, Niccoli C, Elisei R, Viola D, Vitti P, Miccoli P, Basolo F.

Appl Immunohistochem Mol Morphol. 2016 Oct 7. [Epub ahead of print]

PMID:
27753655
10.

Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.

Leo M, Bartalena L, Rotondo Dottore G, Piantanida E, Premoli P, Ionni I, Di Cera M, Masiello E, Sassi L, Tanda ML, Latrofa F, Vitti P, Marcocci C, Marinò M.

J Endocrinol Invest. 2016 Oct 12. [Epub ahead of print]

PMID:
27734319
11.

VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY.

Leo M, Mautone T, Ionni I, Profilo MA, Sabini E, Menconi F, Mazzi B, Rocchi R, Latrofa F, Nardi M, Vitti P, Marcocci C, Marinò M.

Endocr Pract. 2016 Oct;22(10):1177-1186.

PMID:
27732097
12.

Natural history of graves' orbitopathy after treatment.

Menconi F, Leo M, Sabini E, Mautone T, Nardi M, Sainato A, Sellari-Franceschini S, Vitti P, Marcocci C, Marinò M.

Endocrine. 2016 Oct 5. [Epub ahead of print]

PMID:
27709471
13.

The First Meeting of the WHO Guideline Development Group for the Revision of the WHO 1999 Guidelines for Iodine Thyroid Blocking.

Reiners C, Schneider R, Akashi M, Akl EA, Jourdain JR, Li C, Murith C, Van Bladel L, Yamashita S, Zeeb H, Vitti P, Carr Z.

Radiat Prot Dosimetry. 2016 Sep;171(1):47-56. doi: 10.1093/rpd/ncw238.

PMID:
27664997
14.

miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas.

Borrelli N, Denaro M, Ugolini C, Poma AM, Miccoli M, Vitti P, Miccoli P, Basolo F.

Mod Pathol. 2017 Jan;30(1):39-51. doi: 10.1038/modpathol.2016.157.

PMID:
27586203
15.

Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association.

Biondi B, Bartalena L, Chiovato L, Lenzi A, Mariotti S, Pacini F, Pontecorvi A, Vitti P, Trimarchi F.

J Endocrinol Invest. 2016 Dec;39(12):1465-1474.

PMID:
27473077
16.

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations.

Romei C, Casella F, Tacito A, Bottici V, Valerio L, Viola D, Cappagli V, Matrone A, Ciampi R, Piaggi P, Ugolini C, Torregrossa L, Basolo F, Materazzi G, Vitti P, Elisei R.

J Med Genet. 2016 Jul 28. pii: jmedgenet-2016-103833. doi: 10.1136/jmedgenet-2016-103833. [Epub ahead of print]

PMID:
27468888
17.

The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.

Bartalena L, Masiello E, Magri F, Veronesi G, Bianconi E, Zerbini F, Gaiti M, Spreafico E, Gallo D, Premoli P, Piantanida E, Tanda ML, Ferrario M, Vitti P, Chiovato L.

J Endocrinol Invest. 2016 Dec;39(12):1445-1451.

PMID:
27465670
18.

VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY.

Leo M, Mautone T, Ionni I, Profilo MA, Sabini E, Menconi F, Mazzi B, Rocchi R, Latrofa F, Nardi M, Vitti P, Marcocci C, Marinò M.

Endocr Pract. 2016 Jun 30. [Epub ahead of print]

PMID:
27359290
19.

Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).

Bartalena L, Chiovato L, Vitti P.

J Endocrinol Invest. 2016 Oct;39(10):1105-14. doi: 10.1007/s40618-016-0505-x. Review.

PMID:
27319009
20.

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience.

Viola D, Valerio L, Molinaro E, Agate L, Bottici V, Biagini A, Lorusso L, Cappagli V, Pieruzzi L, Giani C, Sabini E, Passannati P, Puleo L, Matrone A, Pontillo-Contillo B, Battaglia V, Mazzeo S, Vitti P, Elisei R.

Endocr Relat Cancer. 2016 Apr;23(4):R185-205. doi: 10.1530/ERC-15-0555. Review.

Items per page

Supplemental Content

Loading ...
Support Center